Company DA32 Life Science Tech Acquisition Corp.

DALS

US23312M1062

Managers

Members of the board

Share class

Company contact information

Sector

Sector Shell Companies

Da32 Life Science Tech Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus its search for business combination targets in separate areas of the life sciences industry, including life sciences tools, diagnostics, synthetic biology, and data and analytics platforms. The Company is not engaged in any business operations and has not generated any revenue.

Managers	Title	Age	Since
Steven Kafka CEO	Chief Executive Officer	54	31/03/21
Chris Wolfe DFI	Director of Finance/CFO	44	31/03/21

Members of the board	Title	Age	Since
E. Hrusovsky BRD	Director/Board Member	63	26/07/21
Keith Crandell BRD	Director/Board Member	63	26/07/21
Nicolas Roelofs BRD	Director/Board Member	66	26/07/21
Steven Kafka CEO	Chief Executive Officer	54	31/03/21
Angela Lai BRD	Director/Board Member	-	26/07/21
Andrew ElBardissi BRD	Director/Board Member	42	26/07/21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	5,000,000	0	0	77.01 %
Stock B	1	20,650,000	19,752,807 ( 95.66 %)	0

DA32 Life Science Tech Acquisition Corp.

345 Park Avenue South 12th floor

10010, New York

address DA32 Life Science Tech Acquisition Corp.(DALS)

Financials

Holding Companies

Holding Companies

Investment Holding Companies

Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+108.23%	7.01B
CHURCHILL CAPITAL CORP VII	+2.71%	987M
PERELLA WEINBERG PARTNERS	+51.02%	976M
ARES ACQUISITION CORPORATION II	+2.39%	669M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
E7 GROUP	-2.15%	593M
ADMIRAL ACQUISITION LIMITED	+10.28%	536M
CAPITOL INVESTMENT CORP. VII	-.--%	500M
AEA-BRIDGES IMPACT CORP.	+4.83%	470M

Shell Companies